
Journal of Organic Chemistry p. 3197 - 3214 (2012)
Update date:2022-08-06
Topics:
Offermann, Daniel A.
McKendrick, John E.
Sejberg, Jimmy J. P.
Mo, Bingli
Holdom, Mary D.
Helm, Birgit A.
Leatherbarrow, Robin J.
Beavil, Andrew J.
Sutton, Brian J.
Spivey, Alan C.
The disruption of the human immunolobulin E-high affinity receptor I (IgE-FcεRI) protein-protein interaction (PPI) is a validated strategy for the development of anti asthma therapeutics. Here, we describe the synthesis of an array of conformationally constrained cyclic peptides based on an epitope of the A-B loop within the Cε3 domain of IgE. The peptides contain various tolan (i.e., 1,2-biarylethyne) amino acids and their fully and partially hydrogenated congeners as conformational constraints. Modest antagonist activity (IC50 ~660 μM) is displayed by the peptide containing a 2,2′-tolan, which is the one predicted by molecular modeling to best mimic the conformation of the native A-B loop epitope in IgE.
View MoreHubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
NINGBO YINZHOU PRECISE COLOR CO.,LTD.
Contact:86-574-88139809 86-574-83033159
Address:Qiming Road,Yinzhou,Ningbo,China
website:http://www.tcfinechem.com/
Contact:18681346930
Address:baifu town,whou district
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Zhangjiagang Golden Reach Fine Chemical Co.,LTD.
Contact:+86-512-6585 6968
Address:Changfu Road, Dongsha Chemical Industry Park, Zhangjiagang City, Jiangsu Province, China
Doi:10.1016/S0040-4039(01)80674-2
(1989)Doi:10.1021/cm202635w
(2011)Doi:10.1246/bcsj.66.245
(1993)Doi:10.1039/c0cc05454b
(2011)Doi:10.3987/COM-10-12099
(2011)Doi:10.1016/0008-6215(90)84223-H
(1990)